Ameriprise Financial Inc. increased its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 59.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 247,402 shares of the company's stock after buying an additional 92,146 shares during the quarter. Ameriprise Financial Inc. owned 0.54% of Azenta worth $12,370,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also bought and sold shares of the company. Ballentine Partners LLC boosted its holdings in Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after acquiring an additional 404 shares during the period. Boothbay Fund Management LLC lifted its position in Azenta by 8.4% in the fourth quarter. Boothbay Fund Management LLC now owns 6,571 shares of the company's stock valued at $329,000 after purchasing an additional 509 shares during the last quarter. Picton Mahoney Asset Management boosted its stake in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after purchasing an additional 532 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Azenta by 14.9% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after purchasing an additional 576 shares during the last quarter. Finally, KBC Group NV grew its holdings in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on AZTA. Needham & Company LLC lowered their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Evercore ISI upped their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Finally, TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th.
Read Our Latest Report on Azenta
Azenta Stock Up 2.8%
Shares of AZTA stock opened at $27.47 on Monday. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of -9.22 and a beta of 1.64. The stock has a fifty day moving average of $30.00 and a 200 day moving average of $41.54. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $63.58.
Azenta (NASDAQ:AZTA - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same quarter in the prior year, the business posted $0.06 EPS. The company's revenue was up 5.1% on a year-over-year basis. Equities research analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.
About Azenta
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Stories
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
